Learn how to take TDM out of the clinic and into your patients' homes with our TDM Research Resource Bundle. With new technologies, remote sampling can now be done conveniently by anyone, anytime, anywhere.
.svg "q3-tdm-resource-bundle-cover-google-ad (2)")
In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In the US, the device is not for use with saliva samples intended for clinical DNA testing. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in some content included here.
Our TDM Research Resource Bundle can help you easily adopt new sample collection technologies in both the field and the lab. Whether you are a doctor looking to build a personalized remote therapeutic drug monitoring program for your patients, or a clinical researcher searching for TDM device sampling alternatives, look no further! When patients can self-manage sample collection at home this helps them adhere to an appropriate drug regimen, while eliminating unnecessary and time-consuming travel to the clinic.
After getting a kidney transplant, patients must get frequent blood draws for therapeutic drug monitoring (TDM) to track blood concentration levels of immunosuppressive drugs,. Immunosuppressive therapy helps a patient's body accept the new organ and remain healthy, but maintaining the appropriate drug level requires many clinic visits for close monitoring by the care team. The 'Count On Me' kidney transplant program at the NHS' Nottingham Children's Hospital in the UK has made things easier for pediatric patients and their families by providing at-home blood collection kits to enable remote TDM.
Being able to self-manage their blood sampling for TDM has improved the quality of life for patients and their families, saving them time, travel, and exposure to contagions.
In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In the US, the device is not for use with saliva samples intended for clinical DNA testing. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in some content included here.
We wanted an easier way for children and their families to get their blood tests done so they wouldn't have to travel so much to visit us. Having a kit that allows patients to do their blood draws at home is fantastic!"
– JJ Kim, MD, Nottingham Children's Hospital, NHS, UK
“We use the blood collection kit at home for our son, who is a kidney transplant recipient. The kit has easy instructions, a finger-prick tool & supplies to collect the samples. We use the included shipping envelopes to post samples to our son’s care provider. The kit saves us time and unnecessary trips to the clinic.”
– Mrs. Lego | Transplant Patient Parent, USA
"The Mitra® devices make sampling in the hospital diagnostics lab environment amenable to workflows used in those labs and accessible to lab staff. Importantly, the Mitra® devices also dramatically improve the sample process, in terms of logistics and costs, and make storage of the samples in the central lab easier, not dependent on a freezer. The costs associated with wet blood sample shipping and storage may have made such work [protein biomarker research / proteomics] prohibitively challenging in the past.”
– Dr. Stephen Pennington of University College Dublin
"VAMS technology allows convenient at-home monitoring and is minimally invasive. It also offers efficiencies in the clinical setting, as providers will have blood results in hand before meeting with the patient."
– Dr. Christophe Stove | Ghent University Hospital
“With Mitra® devices, collecting the blood sample requires only one minute, no more. There is no pain associated with the process, and no excess bleeding. It takes just a few more minutes to register the samples, to place them in an envelope, to put a stamp on it, and to drop it in the mailbox.”
– Dr. Bruno Journe, Specialist in Addictology
Safer-at-home, simpler, smarter, and more convenient.
With remote microsampling, therapeutic drug monitoring (TDM) is more convenient and comfortable thus making compliance with tough drug regimens more achievable. Download this bundle of groundbreaking case studies and research insights.
421 Amapola Ave
Torrance, CA 90501
Call us: 1 (310) 787-8747
info@neoteryx.com
Mitra® is an exempt medical device in the US, CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, and registered with Health Canada. It is intended as a specimen collector and for the storage and transport of biological fluids. Use of the device with blood for diagnostic applications is limited to certain countries and, in the US, for research and non-diagnostic purposes only. In the US, the device is not for use with saliva samples intended for clinical DNA testing. Neoteryx Products are not marketed in the US for clinical diagnostic uses. In other countries, Neoteryx Products may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.
Copyright © 2021 Neoteryx, LLC. All rights reserved.